
Overview
James Cooper, MD, MSc, is clinical director of the Coagulation Program at UPMC Children's Hospital of Pittsburgh. He is also an assistant professor of pediatrics at the University of Pittsburgh School of Medicine. He is board certified in pediatric hematology-oncology and pediatrics.Dr. Cooper earned his medical degree from University of Connecticut School of Medicine. He completed a residency and internship in pediatrics at the University of Connecticut-Connecticut Children's Medical Center followed by a fellowship in pediatric hematology-oncology at UPMC Children's Hospital. Dr. Cooper also earned his master's of science in clinical research at the University of Pittsburgh Institute for Clinical Research Education.In his role as clinical director of the Coagulation Program, Dr. Cooper cares for children with bleeding disorders and thrombosis concerns. As part of that mission, Dr. Cooper and Dr. Tahniat Syed of Adolescent Medicine co-lead a dedicated clinic for young women with menstrual disorders, known as the CHAMP (Comprehensive Hematologic Assessment of Adolescents with Menstrual Problems) Clinic. In addition to coagulation disorders, Dr. Cooper also cares for children with a variety of oncologic and other hematologic problems.Dr. Cooper’s research interests include thrombosis rates in adolescents and young adults versus younger children with cancer and the cost effectiveness of laboratory analysis of clotting disorders in children. He is a member of the American Society of Pediatric Hematology and Oncology, the American Society of Hematology, the Children’s Oncology Group, the Critical Mass Young Adult Alliance, the American Thrombosis & Hemostasis Network, the American Academy of Pediatrics, the Foundation for Women and Girls with Bleeding Disorders, and the Hemostasis and Thrombosis Research Society.View the full list of Dr. Cooper’s publications on PubMed.
Dr. Cooper is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Mesenteric Venous Thrombosis, Venous Thromboembolism (VTE), Hemophilia A, and Blood Clots.
Dr. Cooper is board certified in American Board Of Pediatrics and American Board Of Pediatrics . He is actively involved in clinical research, co-authoring 24 peer reviewed articles and participating in 2 clinical trials. Dr. Cooper is currently accepting new patients.
Specialties
Licenses
Board Certifications
Fellowships
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- OTHER MEDICARE PART D
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- MANAGED MEDICAID PLAN
- HMO
- MANAGED MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
Locations
205 Millers Run Road, Bridgeville, PA 15017
4401 Penn Avenue, Pittsburgh, PA 15224
Additional Areas of Focus
Dr. Cooper has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Pediatric Hematology Oncology In Lawrenceville
Cheryl A. Hillery, MD, is clinical director of Hematology at UPMC Children’s Hospital of Pittsburgh and a professor of Pediatrics within the Division of Hematology-Oncology at the University of Pittsburgh School of Medicine. She is the director of the Pediatric Comprehensive Sickle Cell Program and has led basic, translational, and clinical research studies focused on sickle cell disease. Dr. Hillery is highly rated in 6 conditions, according to our data. Her clinical expertise encompasses Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, and Hemolytic Anemia. Dr. Hillery is board certified in American Board Of Pediatrics and American Board Of Internal Medicine . Dr. Hillery is currently accepting new patients.
Pediatric Hematology Oncology In Lawrenceville
Frederico Xavier, MD, MS, is the associate clinical director for the Hemophilia Center of Western Pennsylvania and an associate professor of Pediatrics at the University of Pittsburgh School of Medicine. He is board-certified in Pediatrics and in Pediatric Hematology/Oncology.Dr. Xavier completed his medical degree, pediatric residency, and fellowship training in Brazil. He then completed a pediatric residency in New York, pediatric hematology and oncology fellowship at St. Jude Children’s Hospital, and then a pediatric hemostasis fellowship at the Hospital for Sick Children in Toronto, Ontario, Canada. Dr. Xavier completed a master’s degree in clinical research at the Indiana University-Purdue University Indianapolis.He has published peer-reviewed articles and book chapters in the field of pediatric hemostasis and is currently awarded with a research grant to study inflammation in Hemophilia. Dr. Xavier also sits in the Newborn Screening and Follow-up Technical Advisory Board for the Pennsylvania Department of Health.Dr. Xavier also practices at the Hemophilia Center of Western Pennsylvania, a state and federally-funded 501(c)3 charitable organization that provides comprehensive medical care to the residents of Western Pennsylvania with hemophilia and other bleeding and clotting disorders. The functions of the center include diagnosis and evaluation of individuals with bleeding disorders; treatment of bleeding episodes and complications; education of the patient and family, the community, and other medical providers; communication and advocacy; supervision of home care; and research and data collection.View the full list of Dr. Xavier’s publications on PubMed. Dr. Xavier is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Hemophilia A, Hemophilic Arthropathy, Hemophilia B, Von Willebrand Disease (VWD), and Spinal Fusion. Dr. Xavier is board certified in American Board Of Pediatrics and American Board Of Pediatrics . Dr. Xavier is currently accepting new patients.
Pediatric Hematology Oncology In Lawrenceville
Jessica Daley, MD, specializes in pediatric hematology and oncology and is certified in pediatrics by the American Board of Pediatrics. She practices at Pediatric Hematology Oncology in Lawrenceville and is affiliated with UPMC Magee-Womens Hospital. She completed her residency at Hasbro Children's Hospital, fellowship at University of Pittsburgh School of Medicine and medical degree at Tufts University School of Medicine. Dr. Daley is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Ewing Sarcoma, Osteosarcoma, and Adult Soft Tissue Sarcoma. Dr. Daley is board certified in American Board Of Pediatrics and American Board Of Pediatrics . Dr. Daley is currently accepting new patients.
Pediatric Hematology Oncology In Lawrenceville
Jean M. Tersak, MD, provides care for pediatric oncology patients and long term survivors of childhood cancer at UPMC Children’s Hospital of Pittsburgh. Dr. Tersak is institutional principal investigator for the UPMC Children’s Oncology Group and director of clinical oncology research within the Division of Pediatric Hematology/Oncology. She is also a professor of pediatrics and clinical and translational science at the University of Pittsburgh School of Medicine and is board-certified in pediatric hematology/oncology.Dr. Tersak earned her bachelor's degree, master’s degree, and medical degree from the University of Pittsburgh. She completed her residency and fellowship at UPMC Children’s Hospital of Pittsburgh.Dr. Tersak is extensively involved in clinical research including the evaluation and treatment of patients with new diagnosis. Her research interests include the late effects, quality of life, and neurocognitive outcomes in survivors of childhood cancer and evaluation and treatment of opsoclonus myoclonus in patients with neuroblastoma. She is a member of the American Society of Clinical Oncology Children’s Oncology Group.View the full list of Dr. Tersak’s publications on PubMed. Dr. Tersak is highly rated in 14 conditions, according to our data. Her clinical expertise encompasses Neuroblastoma, Reticulohistiocytoma, Histiocytosis, Embryonal Tumor with Multilayered Rosettes, and Bone Marrow Aspiration. Dr. Tersak is board certified in American Board Of Pediatrics. Dr. Tersak is currently accepting new patients.
UPMC Children's Hospital Of Pittsburgh, Pediatric Hematology/Oncology
A. Kim Ritchey, MD, is a pediatric hematologist/oncologist and is certified in pediatrics and pediatric hematology/oncology by the American Board of Pediatrics. He is vice-chair of International Affairs of the Department of Pediatrics at UPMC Children’s Hospital of Pittsburgh and is professor of pediatrics at the University of Pittsburgh School of Medicine. He received his medical degree from the University of Cincinnati School of Medicine and completed his pediatric residency at Johns Hopkins Hospital, followed by his fellowship in pediatric hematology/oncology at Yale University. Dr. Ritchey’s clinical interests include all aspects of pediatric hematology and oncology. His career focus is pediatric leukemia and coagulation disorders. He has numerous publications in peer-reviewed journals as well as book chapters and has presented both locally and nationally. He is a member of the American Society of Pediatric Hematology/Oncology where he served as president, as well as the American Society of Hematology, and the American Society of Clinical Oncology. Dr. Ritchey is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Hemophilia B, Hemophilia A, and Leukemia. Dr. Ritchey is board certified in American Board Of Pediatrics and American Board Of Pediatrics . Dr. Ritchey is currently accepting new patients.
Pediatric Hematology Oncology In Lawrenceville
Julia Meade, MD, is a pediatric genetic oncologist certified in pediatric hematology/oncology by the American Board of Pediatrics. She is an Associate Professor of Pediatrics at the University of Pittsburgh School of Medicine in both the divisions of Pediatric Hematology/Oncology and Genetic and Genomic Medicine. Dr. Meade holds a secondary appointment as Associate Professor of Human Genetics in the School of Public Health. She received her medical degree from Texas A&M University School of Medicine and completed her pediatric residency at the University of Colorado, followed by her hematology/oncology fellowship at UT Southwestern Medical Center and her pediatric neuro-oncology fellowship at Northwestern University. Dr. Meade also holds a certificate in cancer risk assessment from the City of Hope. Dr. Meade is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Ewing Sarcoma, Neurofibromatosis Type 1 (NF1), Neurofibromatosis, and Osteosarcoma. Dr. Meade is board certified in American Board Of Pediatrics and American Board Of Pediatrics . Dr. Meade is currently accepting new patients.
Frequently Asked Questions about Dr. James D. Cooper
How do I make an appointment with Dr. James D. Cooper?
You can book an appointment with Dr. James D. Cooper by calling their office at 412-854-5005. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. James D. Cooper a top-rated expert for Mesenteric Venous Thrombosis?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. James D. Cooper is classified as an Advanced expert for Mesenteric Venous Thrombosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. James D. Cooper specialize in?
While Dr. James D. Cooper is a Pediatric Hematology Oncology, they have specific expertise in Mesenteric Venous Thrombosis, Venous Thromboembolism (VTE), and Hemophilia A. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pediatric Hematology Oncology.
Does Dr. James D. Cooper participate in research or clinical trials?
Yes. Dr. James D. Cooper has published 24 articles and abstracts on conditions like Mesenteric Venous Thrombosis. You can view a list of Dr. James D. Cooper's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. James D. Cooper accept my insurance?
Dr. James D. Cooper accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 412-854-5005 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Mesenteric Venous ThrombosisDr. Cooper isAdvanced. Learn about Mesenteric Venous Thrombosis.
- Venous Thromboembolism (VTE)Dr. Cooper isAdvanced. Learn about Venous Thromboembolism (VTE).
- Experienced
- AnemiaDr. Cooper isExperienced. Learn about Anemia.
- Blood ClotsDr. Cooper isExperienced. Learn about Blood Clots.
- Hemolytic AnemiaDr. Cooper isExperienced. Learn about Hemolytic Anemia.
- Hemophilia ADr. Cooper isExperienced. Learn about Hemophilia A.
- HepatoblastomaDr. Cooper isExperienced. Learn about Hepatoblastoma.





